Email address
[email protected]Contact number
+56 22 368 3500Provided by Sargent & Krahn
The protection of pharmaceutical products is one of the few areas where experts agree that legal protection is essential to foster innovation. Indeed, the launch of a pharmaceutical product in the market is a long and difficult process that implies the investment of enormous resources and the generation of a significant amount of necessary information to obtain the regulatory authorization to allow its commercialization, which constitutes one of the most valuable assets of a pharmaceutical company.
Also, and increasingly, the IP aspects of pharmaceutical and agro-chemical products are related to the registration process before the specialized regulatory authorities, considering the need to protect the data that the applicant must provide to obtain the authorization to sell their products. Our attorneys have experience in negotiations and regulatory litigations, and also in the management of the provisions for data protection and are thus in a unique position to advise our clients regarding these matters.
Additionally, the provisions of bioequivalence and biosimilars are becoming increasingly relevant in the process of registration and sale authorizations of pharmaceutical products, because their infringement can lead to the rejection or cancellation of said registration. The attorneys and technicians of our firm can provide the necessary guidance and advice in regulatory matters.
Provided by Chambers
Provided by Sargent & Krahn
Sargent & Krahn represented Incyte Corporation on a filing and issuance of a pharmaceutical patent for cancer treatment.
Provided by Chambers
Sargent & Krahn has a good track record in the market. They stand out for the quality of their advice and their speedy responses.
Sargent & Krahn has a good track record in the market. They stand out for the quality of their advice and their speedy responses.
Provided by Chambers
Juan Pablo Egaña is praised by market commentators for his practice representing pharmaceutical clients in a host of patent matters, including both non-contentious matters and disputes in the Chilean life sciences sector.
Juan Pablo Egaña stands out for his excellent work in the life sciences market.
Cristián Barros frequently represents global pharmaceutical companies in regulatory and patent issues in Chile.
Cristián Barros combines his key knowledge with strong soft skills, making him a pleasure to work with.